The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase
Abstract Parainfluenza virus 3 (PIV3) infection poses a substantial risk to vulnerable groups including infants, the elderly, and immunocompromised individuals, and lacks effective treatments or vaccines. This study focuses on targeting the hemagglutinin-neuraminidase (HN) protein, a structural glyc...
Saved in:
Main Authors: | Rose J. Miller, Ian A. Durie, Aaron D. Gingerich, Mohamed A. Elbehairy, Abigail G. Branch, Riley G. Davis, Nada Abbadi, Melinda A. Brindley, Jarrod J. Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55101-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01) -
Rhabdomyolysis Associated with Parainfluenza Virus
by: Miltiadis Douvoyiannis, et al.
Published: (2013-01-01) -
The Battle against Influenza: The Role of Neuraminidase Inhibitors in Children
by: Upton Allen
Published: (2000-01-01) -
Bone and Joint Infections due to Haemophilus parainfluenzae: Case Report and Review of the Literature
by: Conar R. O’Neil, et al.
Published: (2016-01-01) -
Serological researches for parainfluenza type 3 virus infection in the cattle of konya agriculture management
by: Feridun ÖZTÜRK